Literature DB >> 25975839

Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation.

Mohammad Raeiszadeh1, Annette Pachnio2, Jusnara Begum2, Charles Craddock3, Paul Moss3, Frederick E Chen4.   

Abstract

Entities:  

Keywords:  CD4; CD57; CMV; HLA-Class II tetramers; stem cell transplantation

Mesh：

Substances：

Year:  2015        PMID： 25975839      PMCID： PMC5004434          DOI： 10.3324/haematol.2015.123687

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.

Authors:  Beatrice Ludwig; Frank Bernhard Kraus; Melanie Kipp; Wolfgang Preiser; Rainer Schwerdtfeger; Hans Wilhelm Doerr; Sigune Buxbaum
Journal:  J Clin Virol       Date:  2005-08-19       Impact factor: 3.168

2.  Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

Authors:  Laila E Gamadia; Ester B M Remmerswaal; Jan F Weel; Frederieke Bemelman; René A W van Lier; Ineke J M Ten Berge
Journal:  Blood       Date:  2002-10-31       Impact factor: 22.113

3.  High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.

Authors:  Suparno Chakrabarti; Stephen Mackinnon; Raj Chopra; Panagiotis D Kottaridis; Karl Peggs; Peter O'Gorman; Ronjon Chakraverty; Timothy Marshall; Husam Osman; Premini Mahendra; Charles Craddock; Herman Waldmann; Geoff Hale; Christopher D Fegan; Kwee Yong; Anthony H Goldstone; David C Linch; Donald W Milligan
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

4.  Cytomegalovirus in hematopoietic stem cell transplant recipients.

Authors:  Per Ljungman; Morgan Hakki; Michael Boeckh
Journal:  Hematol Oncol Clin North Am       Date:  2011-02       Impact factor: 3.722

5.  Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.

Authors:  G V Quinnan; N Kirmani; A H Rook; J F Manischewitz; L Jackson; G Moreschi; G W Santos; R Saral; W H Burns
Journal:  N Engl J Med       Date:  1982-07-01       Impact factor: 91.245

6.  Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.

Authors:  Matthew R Pipeling; Emily R John; Jonathan B Orens; Noah Lechtzin; John F McDyer
Journal:  J Infect Dis       Date:  2011-10-21       Impact factor: 5.226

7.  CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals.

Authors:  Laura Crompton; Naeem Khan; Rajiv Khanna; Laxman Nayak; Paul A H Moss
Journal:  Blood       Date:  2007-11-06       Impact factor: 22.113

8.  Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.

Authors:  Ester M M van Leeuwen; Ester B M Remmerswaal; Mireille T M Vossen; Ajda T Rowshani; Pauline M E Wertheim-van Dillen; René A W van Lier; Ineke J M ten Berge
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

9.  Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation.

Authors:  Joseph P Casazza; Michael R Betts; David A Price; Melissa L Precopio; Laura E Ruff; Jason M Brenchley; Brenna J Hill; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Exp Med       Date:  2006-12-11       Impact factor: 14.307

10.  Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.

Authors:  Thomas Widmann; Urban Sester; Barbara C Gärtner; Jörg Schubert; Michael Pfreundschuh; Hans Köhler; Martina Sester
Journal:  PLoS One       Date:  2008-11-04       Impact factor: 3.240
View more
  8 in total

1.  Immunoprofiling reveals cell subsets associated with the trajectory of cytomegalovirus reactivation post stem cell transplantation.

Authors:  Lauren Stern; Helen M McGuire; Selmir Avdic; Barbara Fazekas de St Groth; David Gottlieb; Allison Abendroth; Emily Blyth; Barry Slobedman
Journal:  Nat Commun       Date:  2022-05-11       Impact factor: 17.694

2.  Patient risk stratification and tailored clinical management of post-transplant CMV-, EBV-, and BKV-infections by monitoring virus-specific T-cell immunity.

Authors:  Anastasia Papadopoulou; Kiriakos Koukoulias; Maria Alvanou; Vassilios K Papadopoulos; Zoe Bousiou; Vasiliki Kalaitzidou; Fotini S Kika; Apostolia Papalexandri; Despina Mallouri; Ioannis Batsis; Ioanna Sakellari; Achilles Anagnostopoulos; Evangelia Yannaki
Journal:  EJHaem       Date:  2021-06-01

3.  Human Cytomegalovirus (HCMV)-Specific CD4+ T Cells Are Polyfunctional and Can Respond to HCMV-Infected Dendritic Cells In Vitro.

Authors:  Sarah E Jackson; George X Sedikides; Gavin M Mason; Georgina Okecha; Mark R Wills
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

4.  CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant.

Authors:  Albert C Yeh; Antiopi Varelias; Anupama Reddy; Sierra M Barone; Stuart D Olver; Kate Chilson; Lynn E Onstad; Kathleen S Ensbey; Andrea S Henden; Luke Samson; Carla A Jaeger; Timothy Bi; Kimberly B Dahlman; Tae Kon Kim; Ping Zhang; Mariapia A Degli-Esposti; Evan W Newell; Madan H Jagasia; Jonathan M Irish; Stephanie J Lee; Geoffrey R Hill
Journal:  Blood       Date:  2021-12-30       Impact factor: 25.476

Review 5.  Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?

Authors:  Jennifer A Juno; David van Bockel; Stephen J Kent; Anthony D Kelleher; John J Zaunders; C Mee Ling Munier
Journal:  Front Immunol       Date:  2017-01-23       Impact factor: 7.561

6.  Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium.

Authors:  Annette Pachnio; Miriam Ciaurriz; Jusnara Begum; Neeraj Lal; Jianmin Zuo; Andrew Beggs; Paul Moss
Journal:  PLoS Pathog       Date:  2016-09-08       Impact factor: 6.823

Review 7.  Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Authors:  Lauren Stern; Barbara Withers; Selmir Avdic; David Gottlieb; Allison Abendroth; Emily Blyth; Barry Slobedman
Journal:  Front Microbiol       Date:  2019-05-28       Impact factor: 5.640

8.  A Simple-to-Perform ifn-γ mRNA Gene Expression Assay on Whole Blood Accurately Appraises Varicella Zoster Virus-Specific Cell-Mediated Immunity After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Mathilde Boccard; Anne Conrad; William Mouton; Florent Valour; Chantal Roure-Sobas; Emilie Frobert; Barbara Rohmer; Vincent Alcazer; Hélène Labussière-Wallet; Hervé Ghesquières; Fabienne Venet; Karen Brengel-Pesce; Sophie Trouillet-Assant; Florence Ader
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.